f CD69 is involved in immune cell homeostasis, regulating the T cell-mediated immune response through the control of Th17 cell differentiation. However, natural ligands for CD69 have not yet been described. Using recombinant fusion proteins containing the extracellular domain of CD69, we have detected the presence of a ligand(s) for CD69 on human dendritic cells (DCs). Pulldown followed by mass spectrometry analyses of CD69-binding moieties on DCs identified galectin-1 as a CD69 counterreceptor. Surface plasmon resonance and anti-CD69 blocking analyses demonstrated a direct and specific interaction between CD69 and galectin-1 that was carbohydrate dependent. Functional assays with both human and mouse T cells demonstrated the role of CD69 in the negative effect of galectin-1 on Th17 differentiation. Our findings identify CD69 and galectin-1 to be a novel regulatory receptor-ligand pair that modulates Th17 effector cell differentiation and function. C D69, a C-type lectin, is a member of the natural killer (NK) receptor family and is induced early following activation of leukocytes (1). The physiological role of this receptor, which is persistently expressed by infiltrating leukocytes in different chronic inflammatory diseases, has been studied in CD69-deficient mice in multiple different models of chronic inflammation (2-5). Thus, we have previously described that CD69 Ϫ/Ϫ mice develop an exacerbated form of collagen-induced arthritis (CIA) (3), a Th1 and Th17 cell-mediated autoimmune condition. Moreover, in an experimental model of autoimmune myocarditis (EAM), CD69 negatively regulates cardiac inflammation through the regulation of heart-specific Th17 responses (4). In this regard, we have detected that CD69 modulates the in vitro differentiation of T cells toward the Th17 lineage through the activation of the Jak3/Stat5 inhibitory pathway (5). On the other hand, CD69 negatively regulates the chemotactic responses of effector lymphocytes and dendritic cells (DCs) to sphingosine 1 phosphate (S1P); CD69 can associate with S1P1 in the cell membrane and induce a conformation of S1P1 that favors its internalization and degradation (6-8). It is clear that the identification of cellular ligands for CD69 is a critical next step to better understand the physiological role of this receptor.Galectins are characterized by a common structural fold and a conserved carbohydrate recognition domain (CRD) with a high affinity for beta-galactosides (9). Despite being soluble proteins, galectins are also expressed on the cell surface due to their association with membrane glycoproteins. Thus, galectin-1 (Gal-1) is expressed by most activated but not resting T and B cells, and it is significantly upregulated in activated macrophages and T regulatory lymphocytes (10). In addition, tolerogenic DCs show a high expression of Gal-1 (11), which is rapidly downregulated in response to maturation signals. Furthermore, Gal-1-deficient DCs show a greater immunogenic potential and an impaired ability to halt the inflammatory phenomenon in a ...